Century Therapeutics Earnings Estimate

IPSC Stock  USD 2.17  0.07  3.33%   
By analyzing Century Therapeutics' earnings estimates, investors can diagnose different trends across Century Therapeutics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Century Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Century Therapeutics is projected to generate -0.2425 in earnings per share on the 31st of December 2026. Century Therapeutics earnings estimates show analyst consensus about projected Century Therapeutics EPS (Earning Per Share). It derives the highest and the lowest estimates based on Century Therapeutics' historical volatility. Many public companies, such as Century Therapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Century Therapeutics' earnings estimates, investors can diagnose different trends across Century Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. The current year's Gross Profit is expected to grow to about 7.2 M, whereas Pretax Profit Margin is forecasted to decline to (17.90). Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Century Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Century Stock refer to our How to Trade Century Stock guide.

Century Therapeutics Earnings per Share Projection vs Actual

About Century Therapeutics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Century Therapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Century Therapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Century Therapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-704.1 M-739.3 M
Retained Earnings Total Equity-467.2 M-490.5 M
Earnings Yield(1.83)(1.74)
Price Earnings Ratio(0.56)(0.59)
Price Earnings To Growth Ratio 0.02  0.03 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Century Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Century Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Century Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Century Therapeutics Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Century Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Century Stock refer to our How to Trade Century Stock guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Will Biotechnology sector continue expanding? Could Century diversify its offerings? Factors like these will boost the valuation of Century Therapeutics. Market participants price Century higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Century Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.32)
Revenue Per Share
1.317
Quarterly Revenue Growth
126.677
Return On Assets
(0.04)
Return On Equity
(0.14)
Investors evaluate Century Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Century Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Century Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Century Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Century Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Century Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.